Renal Biomarkers in Heart Failure
JACC: Advances · 2024-02 · 3 (2) · 100765
DOI: 10.1016/j.jacadv.2023.100765 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Advances, 2024-02. Verfasst von Amudha Kumar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Loyola University Medical Center, Maywood, Illinois, USA. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Cystatin C, neutrophil gelatinase-associated lipocalin (NGAL), and kidney injury molecule (KIM)-1 are renal biomarkers increasingly appreciated for their role in the risk stratification and prognostication of heart failure (HF) patients. However, very few have been adopted clinically, owing to the lack of consistency.
Objectives
The authors aimed to study the association between cystatin C, NGAL, and KIM-1 and outcomes, mortality, hospitalizations, and worsening renal function (WRF) in patients with acute and chronic HF.
Methods
We included peer-reviewed English-language articles from PubMed and EMBASE published up to December 2021. We analyzed the above associations using random-effects meta-analysis. Publication bias was assessed using funnel plots.
Results
Among 2,631 articles, 100 articles, including 45,428 patients, met the inclusion criteria. Top-tertile of serum cystatin C, when compared to the bottom-tertile, carried a higher pooled hazard ratio (pHR) for mortality (pHR: 1.59, 95% CI: 1.42-1.77) and for the composite outcome of mortality and HF hospitalizations (pHR: 1.49, 95% CI: 1.23-1.75). Top-tertile of serum NGAL had a higher hazard for mortality (pHR: 2.91, 95% CI: 1.49-5.67) and composite outcome (HR: 4.11, 95% CI: 2.69-6.30). Serum and urine NGAL were significantly associated with WRF, with pHRs of 2.40 (95% CI: 1.48-3.90) and 2.01 (95% CI: 1.21-3.35). Urine KIM-1 was significantly associated with WRF (pHR: 1.60, 95% CI: 1.24-2.07) but not with other outcomes. High heterogeneity was noted between studies without an obvious explanation based on meta-regression.
Conclusions
Serum cystatin C and serum NGAL are independent predictors of adverse outcomes in HF. Serum and urine NGAL are important predictors of WRF in HF.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine, Loyola University Medical Center, Maywood, Illinois, USA.
- Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
- Department of Internal Medicine, St. Vincent's Hospital, Worcester, Massachusetts, USA.
- Department of Community Medicine, Sri Venkateshwaraa Medical College Hospital and Research Center, Pondicherry, India.
- Division of Cardiovascular Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
- Department of Internal Medicine, Louisiana State University, Shreveport, Louisiana, USA.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Kumar, A., Chidambaram, V., Geetha, H. S., Majella, M. G., Bavineni, M., Pona, P. K., Jain, N., Sharalaya, Z., Al'Aref, S. J., Asnani, A., Lau, E. S., & Mehta, J. L. (2024). Renal Biomarkers in Heart Failure. JACC: Advances, 3(2), 100765. https://doi.org/10.1016/j.jacadv.2023.100765
Vancouver
Kumar A, Chidambaram V, Geetha HS, Majella MG, Bavineni M, Pona PK, et al. Renal Biomarkers in Heart Failure. JACC: Advances. 2024;3(2):100765. doi:10.1016/j.jacadv.2023.100765
BibTeX
@article{Kumar2024,
author = {Kumar, Amudha and Chidambaram, Vignesh and Geetha, Harinivas Shanmugavel and Majella, Marie Gilbert and Bavineni, Mahesh and Pona, Pramod Kumar and Jain, Nishank and Sharalaya, Zarina and Al'Aref, Subhi J and Asnani, Aarti and Lau, Emily S and Mehta, Jawahar L},
title = {Renal Biomarkers in Heart Failure},
journal = {JACC: Advances},
year = {2024},
volume = {3},
number = {2},
pages = {100765},
doi = {10.1016/j.jacadv.2023.100765}
}
EUVIMED